• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Tracy T. Batchelor, MD, MPH

Giovanni Armenise - Harvard Professor of Neurology, Department of Neurology, Harvard Medical School

Executive Director, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital

Contact Info

Tracy Batchelor
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Mailstop: Yawkey Center 9E
Phone: 617-724-8770
Fax: 617-724-8769
Email not available

Assistant

Carolyn Chamberlain
Academic Assistant
Hematology/Oncology
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Phone: 617-643-1938
Fax: 617-643-2591
cchamberlain1@partners.org

DF/HCC Program Affiliation

Neuro-Oncology, Co-Leader

DF/HCC Associations

Member, Center Scientific Council

Research Abstract

My work involves the development of novel therapeutics for malignant primary brain tumors. Our investigations in glioblastoma emphasize the development of imaging and tumor markers of sensitivity and resistance to anti-angiogenic therapeutics in preclinical models and humans. We employ novel MRI and PET imaging techniques in order to define subpopulations of glioblastoma patients most likely to benefit from agents targeting vascular endothelial growth factor (VEGF). We are also involved in defining and exploiting alternative pro-angiogenic targets in order to augment and extend responses to anti-VEGF therapeutics. I am also involved in early phase human trials of targeted therapeutics in molecularly defined subsets of glioblastoma.

I have played central roles in defining the optimal diagnostic and treatment pathways for primary CNS diffuse large B-cell lymphoma (PCNSL). I co-founded the International PCNSL Collaborative Group more than a decade ago and I remain the chair of this organization of over 125 hematologists, neurologists and oncologists from more than 20 countries. In the setting of local, national and international studies we have established the currently recommended diagnostic evaluation for newly diagnosed PCNSL patients. I have also spearheaded key chemotherapy trials for PCNSL contributing to currently recommended treatment guidelines for PCNSL.

Publications

View All Publications